trending Market Intelligence /marketintelligence/en/news-insights/trending/Hxx-DYhypMAmJaPPQzJcog2 content esgSubNav
In This List

Mereo BioPharma plans US IPO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Mereo BioPharma plans US IPO

U.K.-based Mereo BioPharma Group PLC plans to conduct a registered IPO in the U.S.

The number of shares and price of the proposed offering have not been determined.

The offering is expected to commence in the first half of 2018, subject to market and other conditions including the U.S. Securities and Exchange Commission review process of the relevant documents.